All News

    Reduced Radiation Dose After Surgery May Improve Survival Rates in HPV-Related Throat Cancer

    January 12th 2022

    A recent study demonstrated that a lower dose of radiation after surgery for HPV-related throat cancer may provide a greater benefit than a higher dose of radiation with chemotherapy.

    How Other Patients With Cancer Helped Me Turn My Situation Around

    January 12th 2022

    One cancer survivor describes the impact of the words of support from other patients with cancer throughout his experience that helped pull him out of devastation.

    ‘Shock to the Heart’: A Cancer Survivor Recalls the Emotions of Her First Chemo Treatment

    January 12th 2022

    After not knowing quite what to expect from her first chemotherapy treatment, colorectal cancer survivor Yla Flores describes the pain she felt in her heart after seeing other patients in worse conditions.

    Trial Underway for Potential First Treatment Option of Newly Diagnosed NPM1-Mutant AML

    January 12th 2022

    A phase 3 trial has begun to examine entospletinib, a selective inhibitor, as a treatment for patients with newly diagnosed NPM1-mutated acute myeloid leukemia.

    Online Sexual Health Support Program for Couples May Aid in Sexual Recovery After Prostate Cancer Treatment

    January 11th 2022

    Sexual dysfunction may often happen after prostate cancer treatment, and the results of one study shown that an online program for both the patient and their partner may help in this aspect of recovery.

    Prophylactic Monoclonal Antibodies Recommended to Protect Certain Patients With Cancer From COVID-19

    January 11th 2022

    The National Comprehensive Cancer Network now recommends prophylactic monoclonal antibodies for immunosuppressed individuals, such as certain patients with cancer.

    Goodbye Cancer Displeasure, Hello Sexual Pleasure

    January 11th 2022

    A cancer survivor explains how she was able to intimately reconnect with her spouse after cancer caused their love life to fizzle for many years.

    Keytruda Has Favorable Results in Adjuvant NSCLC Treatment, a First in Stage 1b-3a

    January 11th 2022

    In an interim analysis from a phase 3 trial of Keytruda, the use of the immunotherapy drug was associated with significantly improved disease-free survival in patients with non-small cell lung cancer.

    Cancer Survivors Share the Unexpected Side Effects Experienced During and After Treatment

    January 11th 2022

    From mouth sores to cold sensitivities as well as a continued taste of chemicals, cancer survivors recently shared some of the more unexpected side effects they experienced during and after treatment.

    Trial Launched to Assess Safety and Efficacy of Novel Drug in Rare Type of Head and Neck Cancer

    January 10th 2022

    A phase 2 trial was recently launched to examine the safety and efficacy of oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma.

    Increased Fiber Intake May Improve Immunotherapy Responses in Patients With Skin Cancer Subtype

    January 10th 2022

    Patients with melanoma who consumed a high-fiber diet may have a better response to immunotherapy, although the benefit was not as great if the fiber was obtained via probiotic supplements.

    Advice on Coping With Fears of the COVID-19 Omicron Variant From a Cancer Survivor

    January 10th 2022

    A cancer survivor offers tips on dealing with the mental gymnastics of wondering whether his COVID-19 vaccine will work against the omicron variant and how more isolation will affect his mental state.

    How Bone Strengtheners Led to a Dental Care Nightmare for One Patient With Cancer

    January 10th 2022

    A woman living with stage 4 cancer explains her painful experience with dental issues that came as a result of cancer treatment.

    FDA Target Dates for Potential Cancer Drug Approvals in Early 2022

    January 10th 2022

    The Food and Drug Administration is expected to decide on whether to approve certain cancer regimens within the first few months of the year. Here’s what patients with cancer should know.

    Instead of New Year’s Resolutions, Make Commitments, Says a Cancer Survivor

    January 9th 2022

    A cancer survivor explains her approach to New Year’s resolutions and how she plans to make her health a priority.

    A Serendipitous Friendship: How My Daughter’s Chemo Nurse Became Her Best Friend After Cancer Treatment

    January 8th 2022

    A mother describes how her daughter formed an unlikely friendship with one of her chemo nurses after her treatment ended.

    Calquence Linked to Fewer Heart-Related, Other Toxicities in Patients With CLL Than Imbruvica

    January 7th 2022

    Treatment with Calquence resulted in fewer toxicities, including atrial fibrillation, flutter and hypertension, in patients with previously treated chronic lymphocytic leukemia, compared with Imbruvica treatment, according to findings from the analysis of a phase 3 trial.

    Digital App May Help Relieve Stress, Depression, Fatigue in Cancer Survivors

    January 7th 2022

    Cancer survivors may experience psychological side effects of cancer and can benefit from stress management interventions, although these in-person services are often limited.

    ‘Dear Body,’ A Tribute From a Cancer Survivor to Her Body

    January 7th 2022

    A breast cancer survivor describes a project she participated in — the Dear Body Project — to thank her body for all that it has endured.

    Former MLB Pitcher Jim Corsi Dies After Cancer, Actress Brittany Daniel Uses Twin as Surrogate and More

    January 7th 2022

    From former Boston Red Sox pitcher Jim Corsi’s death after cancer to how “Sweet Valley High” actress Brittany Daniel’s unique experience after cancer caused pregnancy difficulties, here’s what’s happening in the cancer landscape this week.

    New Drug Combo Boasts Improved Outcomes, Fewer Side Effects in Melanoma

    January 7th 2022

    Relatlimab plus Opdivo improved progression-free survival in patients with untreated, advanced melanoma, and tended to have fewer side effects than other regimens used in this patient population.

    Some Allergy Medications May Positively Influence Immunotherapy Responses in Cancer, But Is Only ‘A Tip of the Iceberg’

    January 6th 2022

    Certain allergy medications like Zyrtec and Claritin may be the key for more patients to tolerate immunotherapy for several cancer types.

    Although Physicians Prefer Colonoscopy, Many Are Implementing Shared Decision-Making With Patients in Colon Cancer Screening

    January 6th 2022

    “It is frequently said that the best screening test is the one patients are willing to complete,” a researcher said. However, some experts note that colonoscopies are the gold standard for detecting and confirming colorectal cancer.

    How I Learned to Live After Learning How to Die From Cancer

    January 6th 2022

    A pancreatic cancer survivor explains how he learned to live after cancer and reflects on lessons learned from the book, “Tuesdays with Morrie.”

    Expert Explores the Relationship Between Down Syndrome and Leukemia

    January 6th 2022

    In this episode of the “Cancer Horizons” podcast, an expert unpacks cancer risks for individuals with Down syndrome and analyzes the results of a recent study about mortality risks for childhood survivors later in life.

    Keytruda/Chemo Combo Is ‘Great News’ for Patients With TNBC, ‘But We Need Much More’

    January 6th 2022

    An expert discusses improvements in survival outcomes for patients with triple-negative breast cancer who received Keytruda plus chemotherapy — now considered the standard of care — but urges that more researched is always needed for this patient population.

    Trial Underway to Assess Efficacy of Novel Radiopharmaceutical Drug in Neuroendocrine Tumors

    January 5th 2022

    The phase 3 COMPOSE trial will look at the efficacy of using 177lu-edotreotide — a novel radiopharmaceutical that is designed to limit radiation exposure to normal tissue — in patients with later stage neuroendocrine tumors.

    Aromatase Inhibitors Reduce Recurrence Risk, But Not Death Rates, in Premenopausal Patients With Breast Cancer

    January 5th 2022

    Premenopausal women with ER-positive breast cancer experienced a decreased rate of recurrence when given an aromatase inhibitor, compared with those given tamoxifen. However, more research is still needed, an expert said.

    Regardless of How Many New Year’s Resolutions People Make, A Patient With Cancer Advises Advocating for Oneself

    January 5th 2022

    After a challenging year due to COVID-19 and rising blood test numbers, a woman living with ovarian cancer shares on what she’s learned and how she’s approaching 2022.

    Upfront Darzalex Combo May Be More Beneficial in the First-Line Setting for Transplant-Ineligible Myeloma Than Alternatives

    January 5th 2022

    An expert from the Mayo Clinic explained that the use of a combination of drugs including Darzalex in the first-line setting may lead to better outcomes for patients with multiple myeloma instead of other first-line standard-of-care options.

    NEXT PAGE
    PREVIOUS PAGE